Protagonist Therapeutics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Protagonist Therapeutics, Inc. now
Current reporting with the operating signal separated from the noise.
Protagonist Therapeutics, Inc. $PTGX Shares Acquired by Stempoint Capital LP
Investors are testing whether Protagonist Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.ADAR1 Capital Management LLC Lowers Stock Holdings in Protagonist Therapeutics, Inc. $PTGX
Investors are testing whether Protagonist Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest PTGX filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Protagonist Therapeutics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →